1Gloria Lena Vega,Myron F. Weiner. Plasma 24S Hydroxycholesterol Response to Statins in Alzheimer’s Disease Patients: Effects of Gender, CYP46, and ApoE Polymorphisms[J] 2007,Journal of Molecular Neuroscience(1):51～55
6Wolozin B. Cholesterol, statins and dementia[J]. Curr Op-in LipidoU 2004,15(6):667.
7Sparks DL, Sabbagh MN, Conno DJ, et al, Atorvastatinfor the treatment of mild to moderate Alzheimer disease [J].Arch Neurol,2005,62(5):753.
8Li J,Zhang M, Xu ZQ,et al. Vascular risk aggravatesthe progression of Alzheimer ’ s disease in a Chinese cohort[J]. JAlzheimers Dis,2010,20(2) :491.
9Locatelli S, Lutiohann D,Schmidt HH,et al. Reductionof plasma 24S-hydroxycholesterol (cerebrosterol) levelsusing high-dosage simvastatin in patients with hypercho-lesterolemia: evidence that simvastatin affects cholesterol-metabolism in the human brain[J], Arch Neurol,2002,59(2):213.
